Fig. 1From: Prevalence and trend of central nervous system–active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional studyAnnual Crude Prevalence of Central Nervous System–Active Medication Polypharmacy by Disease Cohort. EOD indicates, early-onset dementiaBack to article page